Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00089076 | MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma | terminated | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT00002863 | Cryosurgery in Treating Patients With Soft Tissue Sarcoma | terminated | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00003009 |
| Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer |
| terminated |
| Phase 1 |
| 16 |
| University of Southern CaliforniaOTHER |
| 1 |
| May 22, 2014 |
| clinicaltrials |
| NCT00005841 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | terminated | Phase 1 | 15 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183950 | Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy | terminated | Phase 1 / Phase 2 | 12 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00614484 | Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | terminated | Phase 1 / Phase 2 | 28 | Loma Linda UniversityOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01167816 | Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer | terminated | Phase 1 | 9 | University of OklahomaOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01309412 | A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma | terminated | Phase 1 | 9 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | May 19, 2014 | clinicaltrials |
| NCT01403285 | Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma | terminated | Phase 1 | 6 | Immatics Biotechnologies GmbHINDUSTRY | 1 | May 19, 2014 | clinicaltrials |
| NCT01581060 | Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | terminated | Phase 1 / Phase 2 | 41 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT01859351 | Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours | terminated | Phase 1 | 13 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT00684996 | Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer | terminated | Phase 1 / Phase 2 | 5 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00290719 | Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01025570 | A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | terminated | Phase 1 | 3 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01194609 | A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer | terminated | Phase 1 / Phase 2 | 2 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | terminated | Phase 1 | 8 | Rutgers, The State University of New JerseyOTHER | 1 | May 5, 2014 | clinicaltrials |
| NCT01018836 | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | terminated | Phase 1 | 9 | Rutgers, The State University of New JerseyOTHER | 1 | May 2, 2014 | clinicaltrials |
| NCT00933985 | Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 2 | May 1, 2014 | clinicaltrials |
| NCT01655875 | AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia(BMTAMD3100) | terminated | Phase 1 | 1 | Emory UniversityOTHER | 1 | Apr 7, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01426334 | Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate | terminated | Phase 1 | 4 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01491594 | Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 1 | Duke UniversityOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00088023 | Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness | terminated | Phase 1 | 40 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00863395 | Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma(CTCL) | terminated | Phase 1 / Phase 2 | 6 | University of MinnesotaOTHER | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00404521 | A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors | terminated | Phase 1 | 56 | PharmaMarINDUSTRY | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00469820 | Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant | terminated | Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 21, 2014 | clinicaltrials |
| NCT00101907 | Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer | terminated | Phase 1 | 41 | AmgenINDUSTRY | 0 | Mar 20, 2014 | clinicaltrials |
| NCT00943293 | Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies | terminated | Phase 1 | 1 | University of ChicagoOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01641575 | A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin | terminated | Phase 1 | 8 | Clovis Oncology, Inc.INDUSTRY | 2 | Mar 11, 2014 | clinicaltrials |
| NCT00369551 | Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2014 | clinicaltrials |
| NCT01131364 | Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients | terminated | Phase 1 / Phase 2 | 29 | Philogen S.p.A.INDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00096005 | Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00101205 | Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | terminated | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00112684 | Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors | terminated | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00436579 | Sorafenib in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 110 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00701298 | Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00003434 | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | terminated | Phase 1 | 8 | Duke UniversityOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT01407341 | Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer | terminated | Phase 1 | 1 | University of Southern CaliforniaOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00113048 | Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies | terminated | Phase 1 | 24 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00499239 | A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) | terminated | Phase 1 / Phase 2 | 32 | Gilead SciencesINDUSTRY | 3 | Feb 4, 2014 | clinicaltrials |
| NCT01677390 | A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | terminated | Phase 1 | 4 | Seagen Inc.INDUSTRY | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00165594 | A Study of E7070 in Patients With Gastric Cancer | terminated | Phase 1 / Phase 2 | 50 | Eisai Co., Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT01096199 | A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus) | terminated | Phase 1 | 35 | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01063478 | Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC(RAD001) | terminated | Phase 1 | 3 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00265603 | Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer | terminated | Phase 1 | 16 | Atlantic Health SystemOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00337376 | A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers | terminated | Phase 1 | 23 | Yale UniversityOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00819754 | A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer(IXO+A) | terminated | Phase 1 / Phase 2 | 23 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00590603 | Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma(AAV) | terminated | Phase 1 | 25 | Duke UniversityOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT01202890 | Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer | terminated | Phase 1 | 1 | New Mexico Cancer Research AllianceOTHER | 1 | Jan 8, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2014source: clinicaltrials